In our comprehensive synthesis of genetic data from 7,678 PCa patients across 19 studies, we documented a TP53 mutation prevalence of approximately 27% (Figure 1A-B, Supplementary Table 4), with missense mutations being most frequent. The gene discussed is TP53; the disease is posterior cortical atrophy.